Overview


According to FutureWise analysis the market for chronic disease in 2023 is US$ 4.77 billion, and is expected to reach US$ 13.25 billion by 2031 at a CAGR of 13.6%.

Chronic diseases refer to chronic conditions, which are medical conditions that persist over time. It is one of the most prevalent and costly healthcare problems in the world. Chronic disease management acts as an aid to improve patient care in a variety of ways. Chronic disease management is a form of long-term support that provides patients with chronic conditions the necessary knowledge and skills to help them manage their condition. It is mainly the result of integration between various software and service. Chronic disease management can be described as a form of digital healthcare that allows healthcare providers the opportunity to provide educational resources to patients. A chronic condition can be a medical condition, disease, or persistent condition. Chronic refers to a condition in which the course of the disease continues for longer than three months. The most common chronic diseases are diabetes, functional digestive disorders, eczema, and asthma. A fatal illness means that an illness is considered lifelong and will eventually end in death. It is quite possible that an illness can be defined as chronic or terminal. HIV and diabetes, for example, were once considered terminal. But they are now considered chronic as there is insulin available for diabetics. Also, daily HIV drug treatment allows HIV patients to live with their symptoms. Medicine differentiates Chronic conditions from those that are Acute. A severe condition generally affects one area of the body and responds appropriately to treatment. A chronic condition, by contrast, typically affects multiple areas of a person's body and is not fully responsive to treatment. Remission and relapse may be possible for chronic conditions. These are when the disease temporarily disappears and then reappears. Referring to substance abuse disorders, some people consider remission to be a chronic condition, and it is common to discuss periods of remission and/or relapse. Chronic conditions are frequently associated with communicable diseases. These are distinguished by noninfectious causes. Some chronic conditions can be caused by transmissible diseases such as HIV/AIDS. Even with a weak immune system, the aging process can cause many other health issues. Older people need intensive care. An increase in geriatric populations is driving the need for chronic disease management. Healthcare big data is becoming overwhelming due to its sheer quantity and its wide array of clinical and financial information. Understanding trends and patterns in data can help healthcare systems improve patient care and decrease healthcare costs. Chronic obstructive pneumopathy (COPD), which is a long-term illness, occurs when the lungs or air route are damaged. An increase in COPD is driving the demand for chronic disease management.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Chronic Disease Management Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Chronic Disease Management Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Koninklijke Philips N.V.
  • Cognizant TriZetto Software Group Inc
  • Cedar Gate Technologies
  • Xasenet LLC
  • Cliexa Inc
  • Altruista Health
  • Infosys Ltd
  • Pegasystems Inc
  • Epic Systems Corporation
  • Hinduja Global Solutions Ltd
  • NXGN Management LLC
  • ExIServings Holdings Inc
  • Vivify Health Inc
  • Allscripts healthcare LLC
  • Medecision ZeOmega
  • Health Catalyst

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Disease Type

  • Cardiovascular Diseases
  • Diabetes
  • Cancer
  • Asthma
  • Chronic Obstructive Pulmonary Disorders
  • Others

By Type

  • Solutions
  • Services

By End-User

  • Healthcare Providers
  • Healthcare Payers
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Chronic Disease Management Market By Disease Type, By Type, By End-User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Chronic Disease Management Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Chronic Disease Management Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Chronic Disease Management Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Chronic Disease Management Market, By Disease Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Cardiovascular Diseases
        2. Diabetes
        3. Cancer
        4. Asthma
        5. Chronic Obstructive Pulmonary Disorders
        6. Others

  • 8.   Chronic Disease Management Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Solutions
        2. Services

  • 9.   Chronic Disease Management Market, By End-User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Healthcare Providers
        2. Healthcare Payers
        3. Others

  • 10.   North America Chronic Disease Management Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Chronic Disease Management Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Chronic Disease Management Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Chronic Disease Management Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Chronic Disease Management Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Koninklijke Philips N.V.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Cognizant TriZetto Software Group Inc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Cedar Gate Technologies
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Xasenet LLC
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Cliexa Inc
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Altruista Health
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Infosys Ltd
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Pegasystems Inc
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Epic Systems Corporation
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Hinduja Global Solutions Ltd
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. NXGN Management LLC
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. ExIServings Holdings Inc
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Vivify Health Inc
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Allscripts healthcare LLC
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Medecision ZeOmega
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Health Catalyst
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients